Sarah Williams

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle et al. · The Lancet Oncology · 2017 · 1.8K citations

Brca1/2 Mutation, Medicine, Cancer Management +10

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital

Alberto L. García‐Basteiro, Gemma Moncunill, Marta Tortajada et al. · Nature Communications · 2020 · 414 citations · Full text

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Andrés Poveda, Anne Floquet, Jonathan A. Ledermann et al. · The Lancet Oncology · 2021 · 391 citations · Full text

Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

Martin Dennis, Gillian Mead, John Forbes et al. · The Lancet · 2018 · 276 citations · Full text

A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study

James Galloway, Sam Norton, Richard D. Barker et al. · Journal of Infection · 2020 · 217 citations · Full text

Critical Care Medicine, Disease Risk Assessment, Acute Care +13